CLINICAL_TRIALS
trial_result
· 2017-03-29
Clinical Trial Update: Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores [Phase 2]
Summary
Phase 2 trial of docetaxel plus cyclophosphamide for breast cancer with high recurrence scores was terminated; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Breast Neoplasms, Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-03-29